EGM
ALZN icon

Engineers Gate Manager’s Alzamend Neuro ALZN Stock Holding History

Engineers Gate Manager’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32
Closed -$83K – 1819
2021
Q4 		$83K Buy
+32
New +$99K ﹤0.01% 1824

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Engineers Gate Manager's ALZN Position: Q1 2022 in Review

Engineers Gate Manager sold out of Alzamend Neuro (ALZN) in Q1 2022, closing a stake of 32 shares — an estimated $83K sold.

Engineers Gate Manager first reported a position in ALZN in Q4 2021 and held it in 1 quarter. The position peaked at $83K in Q4 2021. 20 funds tracked by Wall St. Rank hold ALZN as of Q1 2022.

  • Engineers Gate Manager reported no remaining Alzamend Neuro position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 32 Alzamend Neuro shares in Q1 2022, an estimated $83K.
  • Engineers Gate Manager first reported a position in Alzamend Neuro in Q4 2021 and held it in 1 quarter.
  • Engineers Gate Manager's Alzamend Neuro position peaked at $83K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Alzamend Neuro as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.